Schröder I
Z Gesamte Inn Med. 1980 Jan 15;35(2):86-91.
On the basis of publications on experimental therapy with transfer factor is tried to show limits and perspective of a new therapeutic principle. The now 10-year-old therapeutic experiences with dialysates of leucocytes and chromatographically cleansed fractions were confirmed by the new investigations of the last years which were evaluated. They show the transfer factor as an effective immune therapeutic for the stimulation of the cellular immunity in a large number of diseases. In these cases a combination with other therapeutic measures proved particularly favourable. Concerning the breadth of use and the chances of success chronic infections are in the foreground. A practical importance of the transfer factor for the treatment of malignant diseases is at present not to be seen. Comprehensive double blind studies with large groups of patients are further necessary, in order to exclude accidental findings for the corresponding picture of the disease and to estimate possible chances of success.
基于关于转移因子实验性治疗的出版物，试图展现一种新治疗原则的局限性和前景。过去10年使用白细胞透析液和经色谱纯化的组分的治疗经验，在过去几年经评估的新研究中得到了证实。这些研究表明，转移因子是一种有效的免疫治疗剂，可刺激多种疾病中的细胞免疫。在这些病例中，与其他治疗措施联合使用被证明特别有益。就使用范围和成功几率而言，慢性感染最为突出。目前尚未发现转移因子在治疗恶性疾病方面具有实际重要性。为了排除疾病相应表现中的偶然发现并评估可能的成功几率，进一步开展针对大量患者的全面双盲研究是必要的。
